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Why is this work important?
Swine leucocyte antigen (SLA) genes are among the most 
important determinants of swine immune responses to 
disease and vaccines. Accurate and comprehensive SLA 
genotyping methods are required to understand how SLA 
gene polymorphisms affect immunity, especially in pigs with 
diverse genetic backgrounds. The work outlined in this 
brief contributes to advances in knowledge required for 
generation of efficient vaccines against swine pathogens 
and diseases, such as African swine fever.
African swine fever (ASF) is a haemorrhagic fever affecting 
pigs. If introduced into a farm, it can kill all the animals 
within a few days. The disease is caused by a large DNA 
virus and the only member of Asfaviridae family, but has 
similarities with the pox viruses, such as chicken pox and 
goat pox, among others. The virus is initially found in cells 
of the macrophage type; but in the later phases of the 
disease, it also infects other cell types such as epithelial 
cells. Distinct clinical symptoms are high fever, redness 
(hemorrhage) of the ears and on other patches of the 
skin, and death. Unfortunately, there are no available 
commercial vaccines or treatment to control or prevent 
ASF virus infection. The only method of preventing ASF is 
by using strict biosecurity methods, e.g. fencing of animals, 
avoiding contact with wild pigs, washing of boots before 
entering pig enclosures, use of quarantine pens for new 
animals, etc. Compartmentalization and zoning of pig 
herds can be used to keep areas ASF-free; however, this 
approach can be difficult to introduce and maintain on a 
large-scale in Africa as pigs often roam freely in rural and 
peri-urban systems. Moreover, poor African pig producers 
are less likely to implement control strategies or report 
disease outbreaks because of a lack of knowledge and 
incentives to do so. Therefore, this disease poses serious 
socio-economic consequences in affected and nearby 
countries and highlights the urgency of developing efficient 
countermeasures against ASF. 
With an estimated 34 million pigs in sub-Saharan Africa, an 
ASF vaccine could benefit from 6–17 million smallholder 
farmers, providing protection in cases of generalized 
outbreaks and preventing outbreaks in nearby areas. As 
the pig population in Africa rises, disease spread could be 
increasingly problematic (Steinaa et al. 2016). 
In the 1960s, ASF became endemic in Spain and Portugal 
and complete eradication took more than 30 years. In 
2007, Africa swine fever was introduced into the Caucasus 
region of Eurasia, where it has spread widely among 
wild boar and domesticated pigs. This virus has caused 
outbreaks in pigs as far west as the easternmost countries 
of the European Union, and it has also been detected 
in wild boar in Iran. The disease now threatens western 
Europe, China and the Far East (CFSPH et al. 2015). 
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What are Swine leukocyte antigens?
SLAs are tissue type antigens in pigs, also more commonly 
known known as major histocompatibility complex 
molecules (MHC). These antigens are very diverse and vary 
among individual pigs. The diversity among the different 
molecules are clustered in a certain region of the molecules. 
This region is responsible for binding of short peptide 
fragments from pathogens, which they present to cells 
from the immune system. This can then trigger the immune 
system to react to the pathogen to clear it from the body.
SLA class I molecules are encoded by three regions in 
the pig genome, SLA-1, SLA-2 and SLA-3 (Lunney et al. 
2009; Renard et al. 2006). SLAs from European pigs are 
characterized far better than their African counterparts. 
Currently, 85 SLA-1, 85 SLA-2 and 36 SLA-3 gene sequences, 
coding for MHC class I molecules, have been published in 
the Immuno Polymorphism Database , but very few, if any, 
originate from African pigs. The origin of African pigs is 
not completely clear, and there is phylogenetic divergence 
between pigs from West and East Africa. Pigs from East 
Africa have high frequencies of genes from pigs in the Far 
East, consistent with data found from African chickens, which 
confirms that livestock were transported from Far East 
over the Indian Ocean thousands of years ago. Later, with 
successive European colonizations, other pig breeds were 
introduced and were mixed with the original pigs, further 
adding to the gene pool (Amills et al. 2013).
Why are SLA sequences interesting?
Each SLA type binds pathogen peptides with a particular 
peptide motif, e.g. the amino acid arginine at position 2 
and lysine at position 9. Different SLA types exhibit a 
preference for different peptides. Hence, the SLA molecules 
‘fit’ with certain peptides in the pathogen, also called 
epitopes. This is important knowledge for the development 
of subunit vaccines. In the process of selecting antigens/
epitopes, for them to be included in a subunit vaccine, 
consideration must be given to the SLAs in the target pig 
population. Knowledge of peptide motifs can also be used 
for prediction of epitopes using neural network algorithms 
such as NetMHCpan (Hoof et al. 2009), developed by 
Danish Technical University (Stryhn et al. 1996).
ILRI sequencing study–findings and next 
steps
ILRI has sequenced the expressed swine leucocyte antigens 
from 34 Kenyan pigs. Messenger RNA, which represents 
expressed genes, was copied to DNA (cDNA) and parts of 
the SLA genes were amplified and sequenced using Illumina 
MiSeq. Many novel sequences were identified.
Three African SLAs have been expressed as protein and 
positional scanning combinatorial peptide library analyses 
have been performed by our Danish collaborators, Soren 
Buus and Anette Stryhn (University of Copenhagen). This 
has generated peptide binding motifs for these three SLA 
molecules (Morten Nielsen, Danish Technical University). 
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The expressed SLAs can now be used to make reagents to 
study the specificity of cellular immune responses to ASF, 
thereby accelerating vaccine development research.
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